Table 2.
Means (SDs) for reaction time indices across conditions and assessment.
| Metric | Placebo | Nonpersonalized | Personalized | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BL | MID | POST | BL | MID | POST | BL | MID | POST | |
| AVOID | 128.75 (69.64) | 106.32 (58.43) | 126.31 (80.44) | 120.83 (68.68) | 106.87 (64.82) | 117.21 (79.64) | 119.76 (57.52) | 98.59 (49.84) | 119.98 (75.4) |
| VIG | 101.67 (47.47) | 83.95 (38.94) | 95.33 (45.66) | 95.74 (41.74) | 84.24 (39.79) | 86.82 (40.96) | 98.74 (46.16) | 78.26 (35.88) | 85.94 (38.16) |
| TRAD | −1.3 (43.73) | −3.05 (42.9) | −3.93 (45.54) | 3.37 (43.11) | −1.26 (37.48) | −5.01 (37.8) | −6.44 (45.91) | −1.93 (29.57) | 3.27 (46.28) |
Abbreviations: AVOID, avoidance response-based attention bias; BL, baseline; MID, mid-treatment; POST, posttreatment; TRAD, traditional attention bias; VIG, vigilance response-based attention bias.